期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
尼洛替尼和伊马替尼对慢性粒细胞白血病表达谱的影响 被引量:5
1
作者 荆凌华 刘松年 +1 位作者 马利敏 杨海平 《中国现代医学杂志》 CAS 2018年第19期28-33,共6页
目的探索尼洛替尼和伊马替尼对慢性粒细胞白血病(CML)细胞基因表达谱的影响,阐明酪氨酸激酶抑制剂(TKI)抑制白血病的分子机制。方法从在线基因表达数据库中下载表达谱数据集GSE19567,利用BRB-Array Tools软件进行质量控制并筛选差异表... 目的探索尼洛替尼和伊马替尼对慢性粒细胞白血病(CML)细胞基因表达谱的影响,阐明酪氨酸激酶抑制剂(TKI)抑制白血病的分子机制。方法从在线基因表达数据库中下载表达谱数据集GSE19567,利用BRB-Array Tools软件进行质量控制并筛选差异表达基因(DEGs),然后分别对差异基因进行GO功能富集分析、KEGG通路富集分析、pathway互作网络和基因互作网络分析。结果共筛选出差异基因519个,其中177个上调表达,342个下调表达。GO富集分析发现DEGs主要涉及小分子代谢、血液凝固、转录调控、细胞增殖与凋亡调控等生物过程,发挥的分子功能集中在蛋白结合、蛋白二聚化、序列特异性DNA结合和ATP结合等。KEGG富集分析发现代谢通路、PI3K-Akt信号通路、Jak-STAT信号通路和HIF-1信号通路等pathway显著富集。网络分析挖掘出的核心基因有SHMT2、CBS、CTH、HK2,核心pathway包括MAPK信号通路、细胞周期和细胞凋亡等。结论酪氨酸激酶抑制剂影响了CML细胞代谢通路和信号转导通路的相关基因,通过细胞周期阻滞和诱导凋亡等机制抑制白血病,为白血病的靶向治疗提供了基础。 展开更多
关键词 白血病 酪氨酸激酶抑制剂 尼洛替尼 伊马替尼 细胞凋亡
下载PDF
SPECIFIC UP-REGULATION OF DNA POLYMERASE BY HUMAN PAPILLOMAVIRUS 16
2
作者 song-nian liu Wu-yun Bai +2 位作者 Russell M Frye Ⅱ Lin Hou Bo Zhang 《Chinese Medical Sciences Journal》 CAS CSCD 2008年第2期108-112,共5页
Obje, etive To analyze how the infection of human papillomavirus 16 ( HPV16 ) affects expression of DNA poly- merase β(DNA polB) with the aim of probing the mechanism of over-expression of DNA polB in human cance... Obje, etive To analyze how the infection of human papillomavirus 16 ( HPV16 ) affects expression of DNA poly- merase β(DNA polB) with the aim of probing the mechanism of over-expression of DNA polB in human cancers. Methods Four fragments of human DNA polB promoter were amplified and constructed into luciferase reporter vec- tor pGL-Basic, generating pGL-BP, pGL-BMH, pGL-BMS, and pGL-BAT constructs respectively, and co-transfected with HPV16 or HPV6 into Hep2 cells. Luciferase activity was assayed 48 hours after transfectiorL Semi-quantitative RT- PCR was used to measure mRNA expression of endogenous DNA polB. Immunohistochemistry and in situ hybridization were used to analyze DNA polB expression and HPV16 or HPV6 infection in 38 cases of cervical lesions respectively. Results With co-transfection of HPV16 and DNA polB promoter-driving reporters into Hep2 cells, pGL-BP re- porter in full-length DNA polB promoter presented markedly elevated luciferase activities ( P 〈 0.05 ). However, the other three mutant reporters: pGL-BMH, pGL-BMS, and pGL-BAT, generated no reporting activities in the presence of HPV16 (P 〉0.05 ). On the contrary, all of polB promoter reporters were little stimulated in co-transfection of HPV6 (P 〉0.05 ). The transfection of HPV16 could enhance the endogenous polB mRNA expression compared with that of HPV6 (3.42 vs. 0.80, P 〈0.05). The DNA polB expression was found in 8 of 10 HPV16-positive cervical intraepi- thelial neoplasia grade Ⅲ( CIN Ⅲ) cases, while was only found in 3 of 11 HPV6-positive condyloma accuminatum cases, but was negative in all chronic cervicitis cases. The correlation of DNA polB expression with HPV16 infection in cervical lesions was significant ( P 〈0.05 ). Conclusions HPV16 is able to specifically stimulate the expression of DNA polB in human epithelial cells through interaction with the core upstream regulatory sequences of DNA polB promoter. Over-expression of DNA polB might be an explanation for the molecular mechanism underlying HPV-related human cancers. 展开更多
关键词 DNA polymerase β human papillomavirus EXPRESSION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部